A toolkit to guide counsel working across jurisdictions through Practical Law's global coronavirus, COVID-19, pandemics and business interruption content. It provides resources for use in the UK, US, China, Australia and Canada.
The Global Coronavirus Toolkit is a collection of resources to assist counsel working across jurisdictions through Practical Law's global coronavirus, COVID-19, pandemics and business interruption content. The Practice Notes, Standard Clauses, Checklists and other resources in this collection cover a range of public health emergency and disaster preparedness topics applicable to attorneys and professionals located in the UK, US, China, Australia and Canada. This Toolkit includes key resources that Practical Law has drafted in response to the Covid-19 pandemic.
Key Global Response: COVID-19
United Kingdom
Practice note, Business Continuity: pandemics, civil emergencies and civil unrest
Practice note, COVID-19: issues for pension scheme trustees
Practice note, Q & A: COVID-19 (Coronavirus) and employment law
Practice note, What's Market: Coronavirus (COVID-19) risk factors and disclosures: tracker
Article, 3VB's finance column: Is Coronavirus a Material Adverse Change?
Article, Covid-19 coronavirus: impact on contractual obligations
Article, Will coronavirus-related losses and liabilities be covered by insurance?
Legal update, AGMs and COVID-19: ICSA guidance
Legal update, Antitrust Agency Response to 2019 Novel Coronavirus Disease (COVID-19)
Legal update, Audit: FRC guidance on issues arising from Covid-19
Legal update, Capital markets and COVID-19: FCA Primary Market Bulletin No 27
Legal update, Charity Commission revises guidance on coronavirus and serious incident reporting
Legal update, CMA warns against exploitative sales and pricing practices during Coronavirus outbreak
Legal update, COVID-19: charities advised to consider halting all public fundraising
Legal update, COVID-19: Commission announces special measures for merger notifications
Legal update, Covid-19: effect on arbitration and latest institutional guidance
Legal update, COVID-19: ESMA recommendations to financial market participants
Legal update, COVID-19: European Commission publishes guidelines on border management measures
Legal update, EBA statement on actions to mitigate Covid-19 impact
Legal update, ECB letter to banks on Covid-19
Legal update, EIOPA statement on actions to mitigate impact of COVID-19 on insurance sector
Legal update, EMA outlines its steps to mitigate impact of coronavirus on supply of medicines (EU)
Legal update, ESMA delays SFTR phase 1 reporting and TR registration obligations
Legal update, FCA expectations for general insurance firms during COVID-19 pandemic
Legal update, FCA information for firms on COVID-19
Legal update, FCA statement on Covid-19
Legal update, FCA statement on property fund suspensions resulting from COVID-19 outbreak
Legal update, Financial reporting: FRC advice on Coronavirus risk disclosures
Legal update, Fundraising Regulator guidance on fundraising events and COVID-19
Legal update, ICAEW's approach to IPs' compliance during the COVID-19 outbreak
Legal update, ICMA and ISLA ask ESMA to delay SFTR reporting go-live date
Legal update, ICO publishes guidance on data protection compliance and COVID-19
Legal update, IPO publishes coronavirus advice for rights applicants
Legal update, Planning Inspectorate publishes COVID-19 guidance
Legal update, PRA supervisory guidance on firms' response to Covid-19
United States
Standard Clause, Continuance or Adjournment Based on COVID-19
Standard Clause, Sample Risk Factor: Coronavirus (COVID-19)
Practice Note, Emergency and Business Continuity Planning
Practice Note, Force Majeure Clauses: Key Issues
Practice Note, Pandemic Flu Preparation and Response
Practice Note, What's Market: Risk Factor Disclosure on Coronavirus (COVID-19)
Continuity of Operations Plan for Local Government Checklist
Emergency and Business Continuity Planning Checklist
Law Department Disaster Recovery Plan Checklist
Preparing for Seasonal Influenza (Flu) and Potential Pandemic Outbreaks: Best Practices Checklist
Sample State and Local Emergency Proclamations for COVID-19
Legal Update, Antitrust Agency Response to 2019 Novel Coronavirus Disease (COVID-19)
Legal Update, CBOE Temporarily Moves to Fully Electronic Trading in Response to COVID-19
Legal Update, COVID-19 Legislation Includes Group Health Plan Coverage Requirements
Legal Update, Expert Q&A: COVID-19 and Employment
Legal Update, Federal Circuit and ITC Announce Changes in Response to COVID-19 Outbreak
Legal Update, Federal Courts Update: Impact of Coronavirus (COVID-19)
Legal Update, FINRA Issues Pandemic-Related Guidance and Regulatory Relief
Legal Update, FTC, FDA, and State Attorneys General Investigate COVID-19 Consumer Complaints
Legal Update, HHS Addresses HIPAA Privacy and Coronavirus
Legal Update, HHS: Coverage for COVID-19 Diagnosis and Treatment Are ACA Essential Health Benefits
Legal Update, IRS Addresses Coverage for COVID-19 Testing and Treatment in HSA/HDHP Guidance
Legal Update, SEC Chairman Jay Clayton Asks Staff to Monitor Coronavirus Disclosures
Legal Update, SEC Issues Relief to Funds and Investment Advisers Affected by COVID-19
Legal Update, SEC Provides Guidance for Conducting Annual Meetings Amid COVID-19 Concerns
Legal Update, Select State Courts Update: Impact of Coronavirus (COVID-19)
Legal Update, US Announces Travel Ban Expansion and New Travel Restrictions
Legal Update, US Copyright Office Announces Changes in Response to COVID-19 Outbreak
Legal Update, USPTO Announces Changes in Response to COVID-19 Outbreak
For information on legislation and regulations enacted in response to COVID-19, see https://coronavirus.skoposlabs.com/ (freely available). We’ve partnered with Skopos Labs to bring you the most advanced AI technology for proposed legislation.
China
Article, Coronavirus outbreak: what can companies do in HR management during the epidemic period?
Article, Coronavirus outbreak: what should companies in China do with employees' holidays?
Article, Coronavirus outbreak: what should companies in China do when employees are back to work?
Article, Does the coronavirus outbreak constitute force majeure?
Legal update, Beijing implements employment rules related to Covid-19
Australia
Article, Coronavirus and bushfires rekindle interest in "force majeure"
Article, COVID-19 and continuous disclosure: how you get ready
Article, COVID-19 and financing arrangements: key considerations for borrowers and lenders
Legal Update, Coronavirus (COVID-19) continuous disclosure and corporate governance considerations
Legal Update, Federal Court releases coronavirus (Covd-19) notice (FCA)
Legal Update, Financial reporting: FRC advice on Coronavirus risk disclosures
Canada
Standard clause, Sample Risk Factor: COVID-19
Practice note, Infectious Disease Outbreaks and the Workplace
Practice note, Pandemic Business Continuity Planning
Legal update, Commercial and Contract Law Implications of the COVID-19 Pandemic
Legal update, Coronavirus and the Workplace: Key Issues for Employers
Legal update, Court Operations Suspended and Hearings Cancelled in Response to COVID-19
Legal Update, Electronic and Virtual Meetings of Shareholders: The New Best Corporate Practice
Legal update, Federal COVID-19 Initiatives: Changes to EI Sickness Benefits and Work-Sharing
European Union
Legal update, COVID-19: CMA announces changes to its working arrangements
Legal update, COVID-19: Commission announces special measures for merger notifications<
Legal update, COVID-19: Commission suspends leniency oral statements procedure
Legal update, COVID-19: ESMA recommendations to financial market participants
Legal update, COVID-19: European Commission publishes guidelines on border management measures
Legal update, COVID-19: European Commission sets up expert group on COVID-19
Legal update, EBA statement on actions to mitigate Covid-19 impact
Legal update, ECB letter to banks on Covid-19
Legal update, EIOPA statement on actions to mitigate impact of COVID-19 on insurance sector
Legal update, EMA outlines its steps to mitigate impact of coronavirus on supply of medicines (EU)